Pharmacological approaches to the challenge of treatment-resistant depression

Although monoaminergic antidepressants revolutionized the treatment of Major Depressive Disorder (MDD) over a half-century ago, approximately one third of depressed patients experience treatment-resistant depression (TRD). Such patients account for a disproportionately large burden of disease, as ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Ionescu, Dawn F., Rosenbaum, Jerrold F., Alpert, Jonathan E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Les Laboratoires Servier 2015
Materias:
State of the Art
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518696/
https://www.ncbi.nlm.nih.gov/pubmed/26246787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518696/
https://www.ncbi.nlm.nih.gov/pubmed/26246787

Ejemplares similares